More Investing
View Older Stories View Newer Stories-
CoreWeave jumps as Goldman Sachs upgrades stock after 25% rout
-
UBS sees attractive risk/reward in three European medtech into Q3 results
-
Analyst says iPhone 18 demand weakness is "intensifying"
-
VinFast misses EPS estimates despite revenue beat
-
UBS adds March rate hike to ECB forecast. Here is why
-
AST SpaceMobile stock rises on European broadband push
-
Top U.S. Transport Stocks to Watch as Peak Shipping Season Approaches: Goldman
-
JPMorgan lifts Intel rating as execution under Tan has been solid
-
Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder
-
Premarket movers: Intel jumps on JPMorgan upgrade; Datadog rallies
-
Silgan stock surges 5.5% on $3.4B Trivium acquisition deal
-
Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
-
Dow Jones, Nasdaq, S&P 500 preview: All eyes on Meta, Tesla, SpaceX earnings
-
U.S. economy is "booming," JPMorgan’s Dimon says
-
CBIZ misses third quarter estimates on earnings and revenue
-
UBS sees EUR/USD recovering as markets turn too pessimistic on Europe
-
Goldman warns high investor conviction could amplify volatility as sentiment shift
-
Fifth Third Bancorp beats earnings estimates on Comerica integration
-
Have bond yields risen too far? JPMorgan’s Matejka sees relief ahead for equities
-
Cleveland-Cliffs stock jumps on third quarter earnings beat
-
Goldman sees SES upside from spectrum payments and European defense demand
-
SoftBank weighs $30 billion Allied Universal deal as Son eyes security robots
-
Anduril may produce new Steelfin missiles in Europe, VP says
-
US budget deficit widens to $1.99 trillion for fiscal 2026
-
Anthropic says Claude solved 25-year cryptography mystery in 30 minutes
-
Investing.com’s stocks of the week
-
City Therapeutics surges in market debut after upsizing $200M IPO
-
California reports 12,000 EV purchases under new rebate program
-
Novartis ends mid-stage trial for Fabhalta in lupus nephritis
-
FAA bans unauthorized drones along US-Mexico border
-
Corporacion America Airports stock rises on September passenger growth
-
Scotiabank sees TSX earnings growth slowing but resource stocks poised to lead
-
RBC raises Shopify price target to $200 on sustained growth outlook
-
Fox Factory shares tumble following CEO departure and outlook reduction
-
Emergent BioSolutions stock falls as CFO plans retirement
-
Ironwood Pharmaceuticals stock falls on CEO transition news
-
NiSource stock gains after Microsoft power deal announcement
-
Goldman Sachs Picks Top African Gold Miners on Growth, Cash Flow Outlook
-
Steelmaker Celsa weighs sale or initial public offering, Bloomberg reports
-
Raymond James gets more bullish on Capri amid favorable setup
-
City Therapeutics allocated no shares to half of IPO orders - report
-
Seagate shares fall after Wells Fargo cuts price target
-
Palo Alto Networks drops on zero-day security flaw concerns
-
Micron Technology stock drops on China chip news and labor dispute
-
Dell Technologies shares fall as analyst and sector concerns persist
-
SanDisk shares fall on inflation data and China chip threat
-
Western Digital shares on chip selloff and price target cut
-
SK hynix shares fall as memory sector faces more pressure
-
Iren shares fall as neocloud selloff extends to third day
-
Moderna shares fall amid valuation concerns
